Clearwater Analytics Holdings, Inc. (CWAN) Q2 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights strong financial performance with a 21% YoY revenue growth projection for Q2 2025 and a 59-61% full-year growth. The Bloomberg partnership and strategic acquisitions support market expansion. The Q&A section reveals positive sentiment, with expectations for accelerated growth and successful cross-selling. Despite management's lack of specificity on some points, the overall outlook is optimistic, especially given the market cap of $4 billion, suggesting a positive stock price movement of 2-8% over the next two weeks.
Key Financial Performance
Total Revenue $181.9 million, up 70% year-over-year. The increase was driven by strong performance in the core business and contributions from acquisitions.
Core Business Revenue $130.6 million, representing a 22% year-over-year organic growth. Growth attributed to traditional drivers and newer areas like international insurance and global asset management.
Annualized Recurring Revenue (ARR) $783.5 million, up 83.4% year-over-year. Organic ARR was $513 million, a 20% year-over-year increase.
Core Net Revenue Retention (NRR) 114%, showing consistent client expansion in the use of Clearwater's services.
Consolidated Net Revenue Retention (NRR) 110%, reflecting the inclusion of acquired businesses.
Adjusted EBITDA $58.3 million, representing 32.1% of revenue and a 74.3% year-over-year increase. This was achieved despite integrating a less profitable acquisition, Enfusion.
Gross Margin 77.4%, exceeding expectations despite the integration of Enfusion, which had a lower gross margin. Core accounting and analytics business gross margin exceeded 80%.
Expense Synergies $20 million achieved within the quarter, contributing to profitability improvements.
Operating Cash Flow $47.1 million, driven by strong non-GAAP earnings and effective working capital management.
Debt Repayment $50 million of revolver repaid within the quarter, reducing total debt to $872 million.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Integrated front-to-back platform: Clearwater, Enfusion, and Beacon are being integrated to deliver a comprehensive front-to-back platform for investment management. This platform will feature a single-instance multi-tenant architecture, real-time data updates, and cross-asset class risk management.
Generative AI initiatives: The company is scaling its generative AI initiatives, including Helios, a proprietary data reconciliation platform, to enhance operational efficiency and portfolio insights.
International insurance and global asset management: Investments in these areas are yielding results, contributing to the company's growth.
Partnership with Bloomberg: A new partnership with Bloomberg aims to deliver a seamless front-to-back solution for large asset managers, enhancing automation and client experience.
Gross margin improvement: Achieved a gross margin of 77.4% in Q2 2025, exceeding expectations despite integrating Enfusion, which had lower profitability.
Expense synergies: Realized $20 million in expense synergies within the first few days of integration.
Acquisitions of Enfusion, Beacon, and Bistro: These acquisitions aim to create a disruptive investment management platform, validated by client and employee feedback.
Reorganization for client focus: The company reorganized its business to serve four markets: insurance, asset managers, hedge funds, and asset owners, aligning product and engineering teams to these verticals.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Integration of Acquired Businesses: The integration of Enfusion and Beacon, while progressing faster than expected, poses risks related to achieving full operational and cultural alignment. There is also a challenge in maintaining profitability and efficiency during the integration process.
Profitability and Margin Expansion: While gross margins have improved, there is a risk of not sustaining these levels as the company continues to integrate businesses with historically lower profitability. Achieving further margin expansion may face operational and market challenges.
Debt Levels: The company has a total debt of $872 million, which, while being repaid, could pose financial risks if cash flow generation slows or economic conditions worsen.
Retention Metrics for Acquired Businesses: Retention metrics for Enfusion are below the company target, and there is a risk that efforts to improve these metrics may not succeed, impacting overall client retention and revenue growth.
Generative AI Initiatives: While generative AI initiatives like Helios are promising, there is a risk of underperformance or delays in realizing their full potential, which could impact operational efficiency and competitive positioning.
Economic and Market Conditions: Economic uncertainties and market conditions could impact revenue growth, particularly in international markets and newly acquired business segments.
Regulatory and Compliance Risks: The integration of multiple platforms and expansion into new markets may expose the company to increased regulatory scrutiny and compliance challenges.
Client and Employee Alignment: Ensuring alignment among 2,600 employees and over 450 clients on the integrated vision poses risks of miscommunication or resistance, which could impact execution and client satisfaction.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Projections: For Q3 2025, total revenue is expected to be $203 million to $204 million, representing a year-over-year growth rate of 75% to 76%. For the full year 2025, total revenue is projected to be between $726 million and $732 million, representing a year-over-year growth rate of approximately 61% to 62%.
EBITDA Guidance: For Q3 2025, adjusted EBITDA is expected to be $65 million, representing a margin of 32%. For the full year 2025, adjusted EBITDA is projected to be between $232 million and $237 million, maintaining an adjusted EBITDA margin of approximately 32%.
Margin Expansion: The company anticipates continued margin expansion through operational efficiencies and scaling generative AI initiatives, including the proprietary Helios platform.
Debt Reduction: The company expects its leverage ratio to be comfortably below 4x by the end of 2025, with ongoing debt repayment efforts.
Integrated Platform Development: The company is progressing towards building a fully integrated front-to-back investment management platform, with a multiyear effort to bring it to market as the key offering.
Client and Market Expansion: The company plans to focus on cross-selling opportunities, launching new products, and reviewing the commercial model to fuel growth in Phase 2 of its strategy.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:How is the company planning to achieve organic ARR growth above 20% next year?
A:The company expects to see acceleration in the second half of the year. Sequential revenue growth in Q1 was minimal, but it stepped up to 3% in Q2. They anticipate faster sequential revenue growth in Q3 and Q4 to achieve roughly 20% organic business growth. ARR is influenced by business bookings and onboarding timing, which can cause variability.
Q:What are the company's thoughts on the Bloomberg partnership and its impact on asset management clients?
A:The company views the Bloomberg partnership as a strong collaboration, particularly for large global asset managers. Bloomberg has a strong position in the market, and the partnership allows the company to provide middle and back-office solutions alongside Bloomberg's front-office capabilities. This partnership addresses a specific market segment and complements the company's existing offerings.
Q:Can you disaggregate the ARR figures for Clearwater, Enfusion, and Beacon?
A:Clearwater's ARR is $513 million, Enfusion's is approximately $220 million to $225 million, and Beacon's is $45 million. These figures are directionally correct.
Q:What investments are being made in the Enfusion business?
A:The company is focused on reaccelerating Enfusion's business. They have set up dedicated product and engineering teams for hedge funds and asset managers, merged Clearwater's efforts with these teams, and established dedicated sales teams. They are also introducing enhanced capabilities like risk management and client reporting. The goal is to achieve sustainable 20% revenue growth over the next two years.
Q:Is there a near-term opportunity for cross-selling into each other's customer base?
A:The largest immediate cross-sell opportunity comes from risk management, which is applicable to hedge funds, asset managers, and insurance clients. The company has also secured a significant win with VKB, Germany's largest public insurer, by offering an integrated front-to-back platform. This demonstrates the potential for cross-selling and integrated solutions.
Q:How should we think about the combined NRR trend post-acquisition?
A:The core NRR has stayed consistent, and the consolidated business calculates NRR at 110%. The company aims to reach 115% NRR by focusing on durable commercial structures and adding additional products to drive growth. They are confident in their ability to achieve this target.
Q:Can you provide guidance on organic versus non-organic growth for Q3 and the full year?
A:The company focuses on consolidated numbers. Clearwater is expected to grow around 20% year-over-year, Enfusion was at a 13% growth rate at the time of acquisition, and Beacon is considered a 20% growing business. These components contribute to the full-year growth outlook.
Q:What is the company's strategy for margin expansion and investments post-acquisition?
A:The company does not anticipate significant increases in R&D or sales investments. They aim to drive gross margin expansion through operational efficiencies. The leadership team has experience in driving margin expansion and is confident in their ability to achieve this while focusing on growth.
Q:What are the company's thoughts on tokenization of real-world assets and its impact on the business?
A:The company believes tokenization and investment in alternative assets will continue to grow. They see themselves as well-positioned to lead in this area due to their comprehensive global portfolio view and single security master. They are optimistic about the opportunities this trend presents.
Q:How is the company leveraging generative AI for efficiency and revenue growth?
A:The company is using generative AI to drive meaningful efficiency improvements, which indirectly accelerates revenue growth. They believe generative AI will eventually lead to new revenue-generating products, with significant adoption expected by 2026. They see a competitive advantage due to their single security master.
Q:What is the company's largest area of investment, and how does it align with customer needs?
A:The largest area of investment is in alternatives, particularly through partnerships like Blackstone and acquisitions like Beacon and Bistro. These investments aim to provide near real-time cross-asset class risk exposure and visualization, addressing the growing demand for solutions in opaque asset classes.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on organic versus non-organic growth for Q3 and the full year, stating they focus on consolidated numbers. They also did not provide clear guidance on the timeline for achieving revenue growth through generative AI, mentioning it as a long-term goal without specific milestones.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI aspect
AI platform
AI version
AIM workflow
ARR Core
Corporate Development
Enfusion margin
Head Corporate
Helios
Inc
LLC
Senior
VKB
action
amortization
analyst
collaboration
component
core driver
efficiency AI
employee
expense synergy
front
function
hedge
improvement Enfusion
instance architecture
insurance asset
interest expense
life cycle
margin improvement
organization
outperformance
power
surprise
team
term margin
trade
vision platform
CWAN Transcript
Clearwater Analytics Holdings, Inc. (CWAN) Q3 2025 Earnings Call Transcript
Positive11-6
The earnings call reveals strong financial performance with a 75%-76% YoY revenue growth and a consistent EBITDA margin of 32%. The company is focusing on margin expansion, debt reduction, and integrated platform development. The Q&A highlights optimism about future growth, particularly in ARR and new pricing models. While there were some vague responses, the overall sentiment, including a robust market strategy and positive financial metrics, suggests a positive stock price movement. Given the market cap, the stock is likely to react positively, but not extremely, suggesting a 2%-8% increase.
Clearwater Analytics Holdings, Inc. (CWAN) Q4 2023 Earnings Call Transcript
Positive9-23
The earnings call shows strong financial performance with significant revenue growth, improved margins, and increased cash flow. Product innovation and geographic expansion plans are promising, though they carry some risks. The Q&A section doesn't highlight major concerns, and the market cap suggests moderate volatility. Despite regulatory and competition risks, the overall sentiment is positive due to strong financial metrics and optimistic guidance, suggesting a stock price increase of 2% to 8%.
Clearwater Analytics Holdings, Inc. (CWAN) Presents At Citi's 2025 Global Technology, Media And Telecommunications Conference (Transcript)
Neutral9-15
Clearwater Analytics Holdings, Inc. (CWAN) Q2 2025 Earnings Call Transcript
Positive8-7
The earnings call highlights strong financial performance with a 21% YoY revenue growth projection for Q2 2025 and a 59-61% full-year growth. The Bloomberg partnership and strategic acquisitions support market expansion. The Q&A section reveals positive sentiment, with expectations for accelerated growth and successful cross-selling. Despite management's lack of specificity on some points, the overall outlook is optimistic, especially given the market cap of $4 billion, suggesting a positive stock price movement of 2-8% over the next two weeks.
CWAN Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
